Clinical trial
Evaluation of Chronotype and Central Sensitization in Patients With Fibromyalgia Syndrome, Cross-sectional Study
NCT06197087 is registered in ClinicalTrials.gov with Oğuzhan Kandemir as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Chronotype and Central Sensitization in Patients With Fibromyalgia Syndrome, Cross-sectional Study
- Lead sponsor
- Oğuzhan Kandemir
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 15, 2023
- Completion date
- December 15, 2024
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronotype, fibromyalgia syndrome